Continuous Improvement and the Expansion of Quality ... - NCQA

Recommendations

Info

T H E S TAT E o f H E A l T H C A R E Q U A l I T y 2 0 1 1 • A P P E N D I C E S APPENDIx 11: HMoS VS. PPoS, MEDICARE PlANS HEdIs EffECtIvEnEss of CarE MEasurEs HMos vs. PPos: MEdICarE avEragEs—2010 MEASURE HMo PPo DIffERENCE safety and Potential Waste Ambulatory Care—ED Visits per 1,000 Member Months 450.3 379 -71.2 Wellness and Prevention breast Cancer Screening 68.5 65.8 -2.7 Chronic disease Management Persistence of beta-blocker Treatment After a Heart Attack 83.1 82.5 -0.6 Disease Modifying Anti-Rheumatic Drug Therapy in Rheumatoid Arthritis 72.8 77.8 5.1 Use of Spirometry Testing in the Assessment and Diagnosis of CoPD 33.9 35.3 1.4 Pharmacotherapy Management of CoPD—bronchodilators 78.2 76.1 -2.2 Pharmacotherapy Management of CoPD—Systemic Corticosteroids 66.6 69.6 3.0 Annual Monitoring for Patients on Persistent Medications—ACE Inhibitors or ARbs 90.7 90.8 0.1 Annual Monitoring for Patients on Persistent Medications—Anticonvulsants 68.2 69.1 0.9 Annual Monitoring for Patients on Persistent Medications—Digoxin 93.1 92.7 -0.5 Annual Monitoring for Patients on Persistent Medications—Diuretics 90.9 91.2 0.4 Annual Monitoring for Patients on Persistent Medications—Combined 90.2 90.6 0.5 Antidepressant Medication Management—Acute Phase 65.0 67.4 2.4 Antidepressant Medication Management—Continuation Phase 51.9 55.7 3.8 follow-Up After Hospitalization for Mental Illness—Within 7 Days Post-Discharge 37.4 39.1 1.6 follow-Up After Hospitalization for Mental Illness—Within 30 Days Post-Discharge 55.4 61.2 5.8 Alcohol and other Drug Dependence Treatment—Engagement 3.7 4.8 1.0 Alcohol and other Drug Dependence Treatment—Initiation 44.6 57.4 12.8 Measures targeted toward older adults fall Risk Management—Discussion 32.8 31.1 -1.8 fall Risk Management—Management 60.1 55.3 -4.8 Potentially Harmful Drug-Disease Interactions in the Elderly— Chronic Renal failure and NSAIDS or Cox-2 Selective NSAIDS* Potentially Harmful Drug-Disease Interactions in the Elderly— Dementia and Tricyclic Antidepressants or Anticholinergic Agents* Potentially Harmful Drug-Disease Interactions in the Elderly— falls and Tricyclic Antidepressants, Antipsychotics and Sleep Agents* 11.6 11.7 0.1 28.7 27.3 -1.4 17.1 16.3 -0.9 Potentially Harmful Drug-Disease Interactions in the Elderly—overall Rate* 23.3 21.8 -1.4 Use of High-Risk Medications in the Elderly—At least one Medication* 22.1 21.9 -0.2 Use of High-Risk Medications in the Elderly—At least Two Medications* 5.1 5.1 -0.1 Management of Urinary Incontinence—Discussion 58.2 57.9 -0.4 Management of Urinary Incontinence—Treatment 36.0 36.3 0.4 Physical Activity in older Adults—Advice 47.9 47.6 -0.3 167
168 N AT I o N A l C o M M I T T E E f o R Q U A l I T y A S S U R A N C E HEdIs EffECtIvEnEss of CarE MEasurEs HMos vs. PPos: MEdICarE avEragEs—2010 MEASURE HMo PPo DIffERENCE Physical Activity in older Adults—Discussion 52.3 53.9 1.5 osteoporosis Testing in older Women 68.5 73.4 4.9 osteoporosis Management in Women Who Had a fracture 20.7 18.5 -2.2 Glaucoma Screening in older Adults 63.8 65.1 1.3 *Lower rates signify better performance.
Page 1 and 2:
Continuous Improvement and the Expa
Page 3 and 4:
2 This Report and the data containe
Page 5 and 6:
4 N AT I o N A l C o M M I T T E E
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
top 10 and bottom 10 states “loca
Page 15 and 16:
Page 17 and 18:
16 this measure has shown steady ga
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
24 HEDIS MEASURES of CARE about HEd
Page 27 and 28:
S A f E T y A N D P o T E N T I A l
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
W E l l N E S S A N D P R E V E N T
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
C H R o N I C D I S E A S E M A N A
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
M E A S U R E S T A R G E T E D A T
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118: M E A S U R E S T A R G E T E D A T
Page 119 and 120: M E A S U R E S T A R G E T E D A T
Page 121 and 122: C o N S U M E R A N D P A T I E N T
Page 129 and 130: 128 N AT I o N A l C o M M I T T E
Page 131 and 132: 130 APPENDIx 1: HEDIS EffECTIVENESS
Page 135 and 136: 134 APPENDIx 2: HEDIS EffECTIVENESS
Page 143 and 144: 142 APPENDIx 4b: ACCREDITED VS. NoN
Page 149 and 150: 148 APPENDIx 6A: ACCREDITED VS. NoN
Page 151 and 152: 150 APPENDIx 6b: ACCREDITED VS. NoN
Page 153 and 154: 152 APPENDIx 7A: PUblICly REPoRTING
Page 159 and 160: 158 APPENDIx 8: PUblICly REPoRTING
Page 167: 166 N AT I o N A l C o M M I T T E
Page 173 and 174: 172 MEASURE N AT I o N A l C o M M
Page 175 and 176: 174 APPENDIx 14b: VARIATIoN IN PlAN
Page 181 and 182: 180 APPENDIx 16A: VARIATIoN IN PlAN
Page 183 and 184: 182 APPENDIx 16b: VARIATIoN IN PlAN
Page 185 and 186: 184 REfERENCES N AT I o N A l C o M
Page 200 and 201: ACkNoWlEDGMENTS Health Plans The 20
show all

Continuous Improvement and the Expansion of Quality ... - NCQA

Create successful ePaper yourself

Delete template?

Save as template?